MXPA04003508A - Anticuerpos humanos que se unen a mn. - Google Patents
Anticuerpos humanos que se unen a mn.Info
- Publication number
- MXPA04003508A MXPA04003508A MXPA04003508A MXPA04003508A MXPA04003508A MX PA04003508 A MXPA04003508 A MX PA04003508A MX PA04003508 A MXPA04003508 A MX PA04003508A MX PA04003508 A MXPA04003508 A MX PA04003508A MX PA04003508 A MXPA04003508 A MX PA04003508A
- Authority
- MX
- Mexico
- Prior art keywords
- binding
- antibodies
- repeat
- human anti
- proteoglycan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3038—Kidney, bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34365701P | 2001-10-18 | 2001-10-18 | |
| US37771602P | 2002-05-02 | 2002-05-02 | |
| PCT/US2002/033470 WO2003033674A2 (en) | 2001-10-18 | 2002-10-18 | Human antibodies that have mn binding and cell adhesion-neutralizing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04003508A true MXPA04003508A (es) | 2004-07-22 |
Family
ID=26993561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04003508A MXPA04003508A (es) | 2001-10-18 | 2002-10-18 | Anticuerpos humanos que se unen a mn. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7462696B2 (https=) |
| EP (1) | EP1438339A4 (https=) |
| JP (2) | JP2005528884A (https=) |
| KR (1) | KR20050037478A (https=) |
| CN (1) | CN1606569A (https=) |
| AR (1) | AR036833A1 (https=) |
| BR (1) | BR0213968A (https=) |
| CA (1) | CA2463943A1 (https=) |
| CO (1) | CO5370684A1 (https=) |
| DO (1) | DOP2002000494A (https=) |
| HU (1) | HUP0600335A2 (https=) |
| IL (1) | IL161411A0 (https=) |
| MX (1) | MXPA04003508A (https=) |
| PE (1) | PE20030473A1 (https=) |
| PL (1) | PL374304A1 (https=) |
| RU (1) | RU2317998C2 (https=) |
| UY (1) | UY27499A1 (https=) |
| WO (1) | WO2003033674A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658924B2 (en) | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| US20090162382A1 (en) * | 2002-03-01 | 2009-06-25 | Bernett Matthew J | Optimized ca9 antibodies and methods of using the same |
| US7504364B2 (en) | 2002-03-01 | 2009-03-17 | Receptors Llc | Methods of making arrays and artificial receptors |
| US7469076B2 (en) | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
| WO2004075855A2 (en) * | 2003-02-26 | 2004-09-10 | Biomed Solutions, Llc | Process for in vivo treatment of specific biological targets in bodily fluid |
| EP1613737A4 (en) | 2003-03-28 | 2008-12-03 | Receptors Llc | ARTIFICIAL RECEPTORS COMPRISING REVERSIBLE IMMOBILIZED CONSTRUCTION BLOCKS AND METHODS |
| EP1664778A2 (en) * | 2003-09-03 | 2006-06-07 | Receptors LLC | Nanodevices employing combinatorial artificial receptors |
| US7884052B2 (en) | 2004-09-03 | 2011-02-08 | Receptors Llc | Combinatorial artificial receptors including tether building blocks on scaffolds |
| EP1789792A2 (en) | 2004-09-11 | 2007-05-30 | Receptors LLC | Combinatorial artificial receptors including peptide building blocks |
| DOP2006000277A (es) | 2005-12-12 | 2007-08-31 | Bayer Pharmaceuticals Corp | Anticuerpos anti mn y métodos para su utilización |
| US20140273033A1 (en) * | 2007-04-12 | 2014-09-18 | Universiteit Hasselt | Biomarkers for multiple sclerosis |
| JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
| EP2285409B1 (en) * | 2008-05-30 | 2016-04-20 | XBiotech, Inc | Il-1 alpha antibodies |
| MX338711B (es) | 2012-10-12 | 2016-04-28 | Medimmune Ltd | Pirrolobenzodiazepinas y conjugados de las mismas. |
| MX362970B (es) | 2013-03-13 | 2019-02-28 | Medimmune Ltd | Pirrolobenzodiazepinas y conjugados de las mismas. |
| CN106662578B (zh) * | 2014-04-03 | 2021-11-12 | 艾勒詹尼斯有限责任公司 | 用于检测食物变态反应的肽、试剂和方法 |
| EP3193940A1 (en) | 2014-09-10 | 2017-07-26 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| EP3525829A1 (en) | 2016-10-11 | 2019-08-21 | Medimmune Limited | Antibody-drug conjugates with immune-mediated therapy agents |
| CA3098103A1 (en) | 2018-05-23 | 2019-11-28 | Adc Therapeutics Sa | Molecular adjuvant |
| US20230372528A1 (en) | 2020-10-16 | 2023-11-23 | University Of Georgia Research Foundation, Inc. | Glycoconjugates |
| GB202102396D0 (en) | 2021-02-19 | 2021-04-07 | Adc Therapeutics Sa | Molecular adjuvant |
| EP4426727A2 (en) | 2021-11-03 | 2024-09-11 | Hangzhou Dac Biotech Co., Ltd. | Specific conjugation of an antibody |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| DE69120146T2 (de) * | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| US6297051B1 (en) * | 1997-01-24 | 2001-10-02 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
| AU2861695A (en) * | 1994-06-15 | 1996-01-05 | Ciba Corning Diagnostics Corp. | Mn gene and protein |
| ES2296412T3 (es) * | 1998-10-23 | 2008-04-16 | Institute Of Virology | Gen y proteina mn. |
| US6689744B2 (en) * | 2000-09-22 | 2004-02-10 | Genentech, Inc. | Notch receptor agonists and uses |
-
2002
- 2002-10-16 AR ARP020103877A patent/AR036833A1/es unknown
- 2002-10-17 UY UY27499A patent/UY27499A1/es not_active Application Discontinuation
- 2002-10-17 DO DO2002000494A patent/DOP2002000494A/es unknown
- 2002-10-18 BR BR0213968-5A patent/BR0213968A/pt not_active IP Right Cessation
- 2002-10-18 CO CO02094163A patent/CO5370684A1/es unknown
- 2002-10-18 RU RU2004115112/13A patent/RU2317998C2/ru not_active IP Right Cessation
- 2002-10-18 US US10/273,541 patent/US7462696B2/en not_active Expired - Fee Related
- 2002-10-18 MX MXPA04003508A patent/MXPA04003508A/es not_active Application Discontinuation
- 2002-10-18 CA CA002463943A patent/CA2463943A1/en not_active Abandoned
- 2002-10-18 IL IL16141102A patent/IL161411A0/xx unknown
- 2002-10-18 PE PE2002001031A patent/PE20030473A1/es not_active Application Discontinuation
- 2002-10-18 WO PCT/US2002/033470 patent/WO2003033674A2/en not_active Ceased
- 2002-10-18 CN CNA028254880A patent/CN1606569A/zh active Pending
- 2002-10-18 EP EP02786449A patent/EP1438339A4/en not_active Withdrawn
- 2002-10-18 JP JP2003536404A patent/JP2005528884A/ja active Pending
- 2002-10-18 KR KR1020047005716A patent/KR20050037478A/ko not_active Withdrawn
- 2002-10-18 PL PL02374304A patent/PL374304A1/xx not_active Application Discontinuation
- 2002-10-18 HU HU0600335A patent/HUP0600335A2/hu unknown
-
2008
- 2008-12-08 US US12/330,504 patent/US20100240100A1/en not_active Abandoned
-
2010
- 2010-02-01 JP JP2010020670A patent/JP2010260845A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20030077277A1 (en) | 2003-04-24 |
| HUP0600335A2 (en) | 2006-08-28 |
| PE20030473A1 (es) | 2003-06-26 |
| DOP2002000494A (es) | 2004-05-31 |
| JP2010260845A (ja) | 2010-11-18 |
| CA2463943A1 (en) | 2003-04-24 |
| PL374304A1 (en) | 2005-10-03 |
| US20100240100A1 (en) | 2010-09-23 |
| UY27499A1 (es) | 2003-05-30 |
| WO2003033674A3 (en) | 2003-08-21 |
| KR20050037478A (ko) | 2005-04-22 |
| IL161411A0 (en) | 2004-09-27 |
| RU2317998C2 (ru) | 2008-02-27 |
| CN1606569A (zh) | 2005-04-13 |
| CO5370684A1 (es) | 2004-02-27 |
| EP1438339A2 (en) | 2004-07-21 |
| RU2004115112A (ru) | 2005-04-27 |
| WO2003033674A2 (en) | 2003-04-24 |
| EP1438339A4 (en) | 2008-08-27 |
| AR036833A1 (es) | 2004-10-06 |
| BR0213968A (pt) | 2005-05-10 |
| JP2005528884A (ja) | 2005-09-29 |
| US7462696B2 (en) | 2008-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04003508A (es) | Anticuerpos humanos que se unen a mn. | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| WO2004001381A3 (en) | Novel raag10 cell surface target and a family of antibodies recognizing that target | |
| AR113225A2 (es) | Anticuerpo monoclonal aislado que se une específicamente a cxcr4 humano expresado sobre la superficie de una célula y que es capaz de inducir apoptosis de célula tumorales cxcr4⁺ in vivo | |
| MY137078A (en) | Recombinant antibodies associated to gangliosides. their use indiagnosis and treatment of tumors. | |
| WO2004074320A8 (en) | Therapeutic targets in cancer | |
| MX9504802A (es) | Anticuerpos anti-egfr y fvs de cadena simple anti-egfr. | |
| WO2006099141A3 (en) | Anti-mesothelin antibodies | |
| JP2009529497A5 (https=) | ||
| PH12012501006A1 (en) | Compositions and methods relating to anti-igf-1 receptor antibodies | |
| WO2005012493A3 (en) | Anti-cd19 antibodies | |
| WO2004032857A3 (en) | Antibody therapy | |
| EP2559705A3 (en) | Anti-activin a antibodies and uses thereof | |
| MY144620A (en) | Recombinant antibodies and fragments which recognize n glycolil gm3 ganclioside and its use in diagnosis and treatment of tumors | |
| UA90082C2 (ru) | Выделенное моноклональное антитело человека, которое специфически связывается с cd25 человека и ингибирует связывание il-2 с cd25 | |
| WO2007109376A3 (en) | Anti-tumor cell antigen antibody therapeutics | |
| EP1383785A4 (en) | RECOMBINANT, TUMOR-SPECIFIC ANTIBODIES AND THEIR USE | |
| AU9021898A (en) | Prostate tumor polynucleotide and antigen compositions | |
| Rochaix et al. | PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen | |
| ATE412756T1 (de) | Verfahren zur krebsdiagnose mittels eines chimärischen toxin | |
| CA3241997A1 (en) | Fully human antibody targeting gprc5d and chimeric antigen receptor (car) and use thereof | |
| WO2020223392A3 (en) | Cancer associated antibody compositions and methods of use | |
| EP2431050A8 (en) | Methods of treating cancer using IL-21 and monoclonal antibody therapy | |
| WO2004003155A3 (en) | Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors | |
| AU3556901A (en) | Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |